Brain tumors are a major cause of cancer-related death, and metastatic brain tumors are particularly difficult to treat. Brain tumors pose significant challenges to scientists in terms of understanding their development and progression, and finding effective treatment...
A Beacon of Innovation and Resilience in Biotech's Challenging Landscape This article provides an overview of the recent grand opening of ChemPartner’s Boston R&D Center of Excellence, written for the broader global scientific community who may not have been able...
Unlocking the Potential of Targeted Protein Degradation In the realm of novel therapeutics, targeted protein degradation has serendipitously emerged as a game-changer, transforming "undruggable" proteins into viable candidates for therapeutic intervention. By...
Homing in on the tumor: the magic bullet of cancer therapy Antibody-drug conjugates (ADCs) have revolutionized oncotherapy, achieving significant clinical success in multiple cancer types. Hailed as a “magic bullet” of precision medicine, ADCs improved therapeutic...
Psoriasis: Patient Impact and the Path to Innovation Psoriasis is more than a skin condition, it is often a lifelong, systemic autoimmune disease that may increase the risk of other serious health complications such as heart disease and diabetes, and have a...